NCT01575873 Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids Status COMPLETED Phase PHASE3
NCT01575834 Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis Status COMPLETED Phase PHASE3
NCT01572545 Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass Status COMPLETED Phase NA
NCT01545648 Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer Status TERMINATED Phase PHASE2
NCT01495000 A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab Status COMPLETED Phase PHASE3
NCT01465568 Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis Status COMPLETED Phase PHASE4
NCT01464931 Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis Status COMPLETED Phase PHASE1
NCT01457950 A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab Status COMPLETED Phase PHASE3
NCT01419717 Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer Status COMPLETED Phase PHASE3
NCT01358669 Effect of Denosumab on Inflammatory Osteolytic Lesion Activity in Total Hip Arthroplasty Status COMPLETED Phase PHASE2
NCT01345019 Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma Status COMPLETED Phase PHASE3
NCT01294397 Effects of Denosumab on the Pharmacokinetics of Etanercept Status TERMINATED Phase PHASE1
NCT01221727 The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam Status COMPLETED Phase PHASE1
NCT01077154 Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE) Status TERMINATED Phase PHASE3
NCT00936897 A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates Status COMPLETED Phase PHASE3
NCT00926380 Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis Status COMPLETED Phase PHASE2
NCT00925600 Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Status COMPLETED Phase PHASE3
NCT00919711 Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate Therapy Status COMPLETED Phase PHASE3
NCT00896532 Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density Status COMPLETED Phase PHASE2